 |
 |
|
|
|
| Mosapride Citrate |
 |
| (¡¾)- 4 –Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide citrate |
 |
| 112885-42-4 |
 |
Product name Mosapride Citrate
CAS NO 112885-42-4
It is dihydrate of (¡¾)- 4 –
Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide citrate .Calculated on anhydrous matter, the assay of C21H25ClFN3O3.C6H8O7 is not less than 98.5£¥.
Molecular formula C21H25ClFN3O3.C6H8O7.2H2O
Molecular weight 650.05
Storage Sealed, in cool and dark place.
Developed by Takeda in 1996, Mosapride Citrate is the best drug of gastric motility. It is third generation of drug for gastric motility.
|
 |
Product name Mosapride Citrate
CAS NO 112885-42-4
It is dihydrate of (¡¾)- 4 –
Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide citrate .Calculated on anhydrous matter, the assay of C21H25ClFN3O3.C6H8O7 is not less than 98.5£¥.
Molecular formula C21H25ClFN3O3.C6H8O7.2H2O
Molecular weight 650.05
Storage Sealed, in cool and dark place.
Developed by Takeda in 1996, Mosapride Citrate is the best drug of gastric motility. It is third generation of drug for gastric motility.
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
